​

Cigna (CI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CI Stock Forecast

Cigna stock forecast is as follows: an average price target of $400.00 (represents a 44.45% upside from CI’s last price of $276.92) and a rating consensus of 'Buy', based on 27 wall street analysts offering a 1-year stock forecast.

CI Price Target

The average price target for Cigna (CI) is $400.00 based on 1-year price targets from 27 Wall Street analysts in the past 3 months, with a price target range of $400.00 to $400.00. This represents a potential 44.45% upside from CI's last price of $276.92.

CI Analyst Ratings

Buy

According to 27 Wall Street analysts, Cigna's rating consensus is 'Buy'. The analyst rating breakdown for CI stock is 0 'Strong Buy' (0.00%), 24 'Buy' (88.89%), 3 'Hold' (11.11%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Cigna Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 25, 2024Jessica TassanPiper Sandler$400.00$338.8018.06%44.45%
May 29, 2024Michael HaRobert W. Baird$388.00$332.9216.54%40.11%
May 06, 2024David WindleyJefferies$407.00$341.5019.18%46.97%
May 03, 2024Michael WiederhornOppenheimer$400.00$344.5016.11%44.45%
May 03, 2024Sarah JamesRaymond James$400.00$344.5016.11%44.45%
May 03, 2024Ben HendrixRBC Capital$384.00$344.5011.47%38.67%
Feb 05, 2024Ben HendrixRBC Capital$354.00$324.069.24%27.83%
Feb 05, 2024Ann HynesMizuho Securities$370.00$324.0614.18%33.61%
Feb 05, 2024Sarah JamesRaymond James$372.00$324.0614.80%34.33%
Feb 01, 2024George HillDeutsche Bank$370.00$307.3220.40%33.61%
Feb 08, 2023Leerink Partners$335.00$289.0015.92%20.97%
Feb 07, 2023Raymond James$350.00$288.4421.34%26.39%
Feb 06, 2023Stephens$370.00$289.1227.98%33.61%
Jan 06, 2023Morgan Stanley$365.00$301.9520.88%31.81%
Nov 23, 2022Morgan Stanley$347.00$320.908.13%25.31%
Nov 06, 2022John RansomRaymond James$370.00$322.1314.86%33.61%
Jul 26, 2022David MacDonaldTruist Financial$330.00$272.6321.04%19.17%
Jul 14, 2022David WindleyJefferies$271.00$273.75-1.00%-2.14%
Jun 22, 2022Ricky GoldwasserMorgan Stanley$296.00$257.6014.91%6.89%
Jun 18, 2022George HillDeutsche Bank$284.00$244.5216.15%2.56%
May 09, 2022Ann HynesMizuho Securities$291.00$263.9910.23%5.08%
Apr 20, 2022Stephens$290.00$265.609.19%4.72%
Apr 11, 2022David MacDonaldTruist Financial$290.00$254.1214.12%4.72%
Mar 02, 2022Ann HynesMizuho Securities$266.00$240.5110.60%-3.94%
Jan 06, 2022Steve BaxterWells Fargo$278.00$226.4722.75%0.39%
Dec 21, 2021Lisa GillJ.P. Morgan$248.00$219.2013.14%-10.44%
Dec 14, 2021Nathan RichGoldman Sachs$233.00$215.608.07%-15.86%
Nov 18, 2021Kevin CaliendoUBS$244.00$216.6312.63%-11.89%
Nov 08, 2021A.J. RiceCredit Suisse$300.00$216.0538.86%8.33%
Nov 04, 2021Michael NewshelEvercore ISI$230.00$211.098.96%-16.94%
Sep 10, 2021Kevin FischbeckBank of America Securities$225.00$202.7111.00%-18.75%
Sep 09, 2021Gary TaylorCowen & Co.$235.00$211.8810.91%-15.14%
Aug 09, 2021John RansomRaymond James$275.00$208.1432.12%-0.69%
Aug 06, 2021Steven ValiquetteBarclays$275.00$206.3233.29%-0.69%
Aug 06, 2021Scott FidelStephens$270.00$206.3230.86%-2.50%
Aug 06, 2021Michael WiederhornOppenheimer$285.00$206.3238.13%2.92%
Aug 05, 2021Steven HalperCantor Fitzgerald$250.00$203.2722.99%-9.72%
Apr 26, 2021Justin LakeWolfe Research$294.00$244.8520.07%6.17%

The latest Cigna stock forecast, released on Jun 25, 2024 by Jessica Tassan from Piper Sandler, set a price target of $400.00, which represents a 18.06% increase from the stock price at the time of the forecast ($338.80), and a 44.45% increase from CI last price ($276.92).

Cigna Price Target by Period

1M3M12M
# Anlaysts--10
Avg Price Target--$384.50
Last Closing Price$276.92$276.92$276.92
Upside/Downside-100.00%-100.00%38.85%

In the current month, the average price target of Cigna stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cigna's last price of $276.92. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 04, 2024Piper SandlerOverweightOverweightHold
Oct 23, 2024StephensBuyBuyHold
Oct 01, 2024StephensBuyBuyHold
Sep 27, 2024BernsteinOutperformOutperformHold
Sep 17, 2024JefferiesBuyBuyHold
Sep 09, 2024StephensOutperformOutperformHold
Aug 19, 2024StephensOutperformOutperformHold
Aug 02, 2024Raymond JamesOutperformOutperformHold
Aug 02, 2024BarclaysOverweightOverweightHold
Jun 26, 2024Raymond JamesOutperformOutperformHold
Jun 25, 2024Piper SandlerOverweightInitialise
May 30, 2024UBSBuyBuyHold
May 06, 2024JefferiesBuyBuyHold
May 03, 2024OppenheimerOutperformOutperformHold
May 03, 2024Cantor FitzgeraldOverweightOverweightHold
May 03, 2024RBC CapitalOutperformOutperformHold
Mar 04, 2024RBC CapitalUnderperformUnderperformHold
Mar 04, 2024Wells FargoBuyBuyHold
Feb 05, 2024Mizuho SecuritiesBuyBuyHold
Feb 05, 2024RBC CapitalSector PerformOutperformUpgrade
Feb 05, 2024Cantor FitzgeraldNeutralOverweightUpgrade
Feb 01, 2024RBC CapitalSector PerformSector PerformHold
Feb 01, 2024OppenheimerUnderperformUnderperformHold
Feb 01, 2024Deutsche BankHoldBuyUpgrade
Jan 04, 2024RBC CapitalSector PerformSector PerformHold
Jan 04, 2024BernsteinMarket PerformOutperformUpgrade
Jun 06, 2023Compass PointBuyInitialise
Jun 06, 2023UBSNeutralDowngrade
Jun 06, 2023CitigroupNeutralDowngrade
Jun 06, 2023BarclaysEqual-WeightDowngrade
Jun 06, 2023LaidlawHoldDowngrade
Jun 06, 2023Janney MontgomeryBuyInitialise
Jun 06, 2023Atlantic EquitiesOverweightInitialise
Jun 06, 2023WedbushOutperformInitialise
Jun 06, 2023BenchmarkBuyInitialise
Jun 02, 2023Itau BBAOutperformUpgrade
Apr 21, 2023Cantor FitzgeraldNeutralInitialise
Apr 05, 2023Raymond JamesStrong BuyOutperformUpgrade
Apr 05, 2023Raymond JamesOverweightStrong BuyUpgrade
Mar 01, 2023Bank of America SecuritiesNeutralBuyUpgrade
Feb 23, 2023Raymond JamesOverweightOverweightHold
Feb 08, 2023SVB LeerinkMarket PerformMarket PerformHold
Feb 07, 2023Raymond JamesOutperformOutperformHold
Feb 06, 2023StephensOverweightOverweightHold
Jan 06, 2023Morgan StanleyOverweightOverweightHold
Jan 03, 2023Wells FargoOverweightEqual-WeightDowngrade
Nov 06, 2022Raymond JamesStrong BuyStrong BuyHold
Oct 26, 2022ScotiabankSector OutperformUpgrade
Aug 24, 2022BMO CapitalOutperformOutperformHold
Aug 08, 2022Wells FargoOverweightOverweightHold
Aug 08, 2022Credit SuisseOutperformOutperformHold
Aug 08, 2022OppenheimerOutperformOutperformHold
Aug 05, 2022StephensBuyBuyHold
Jul 14, 2022JefferiesBuyDowngrade
Jun 22, 2022Morgan StanleyOverweightUpgrade
Jun 18, 2022Deutsche BankHoldHoldHold
May 26, 2022Bank of America SecuritiesNeutralUpgrade
May 09, 2022Cowen & Co.OutperformUpgrade
May 09, 2022Mizuho SecuritiesBuyBuyHold
Feb 22, 2022SVB LeerinkMarket PerformMarket PerformHold
Jan 12, 2022BernsteinMarket PerformMarket PerformHold

Cigna's last stock rating was published by Piper Sandler on Nov 04, 2024. The company gave CI a "Overweight" rating, the same as its previous rate.

Cigna Financial Forecast

Cigna Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$51.11B$49.05B$48.59B$46.46B$45.74B$45.20B$45.38B$43.69B$45.77B$44.33B$43.19B$40.98B$41.87B$40.98B$39.30B$38.44B$38.34B$38.61B
Avg Forecast$69.47B$69.65B$64.84B$62.27B$65.05B$65.26B$61.90B$59.76B$63.16B$59.47B$58.27B$56.53B$48.91B$48.14B$47.29B$45.59B$45.88B$44.77B$44.49B$43.38B$43.91B$42.94B$41.28B$40.21B$40.04B$39.30B$37.87B$37.09B$35.62B$35.04B
High Forecast$72.25B$72.44B$67.44B$64.77B$67.66B$67.88B$64.38B$61.84B$66.58B$59.50B$58.28B$56.56B$49.57B$49.60B$49.19B$47.41B$47.72B$44.77B$44.49B$43.38B$43.91B$42.94B$41.28B$40.21B$40.04B$39.30B$37.87B$37.09B$35.62B$35.04B
Low Forecast$66.06B$66.23B$61.65B$59.21B$61.86B$62.06B$58.86B$57.12B$59.08B$59.44B$58.26B$56.50B$48.01B$47.01B$44.97B$43.35B$43.63B$44.77B$44.49B$43.38B$43.91B$42.94B$41.28B$40.21B$40.04B$39.30B$37.87B$37.09B$35.62B$35.04B
# Analysts999988810126749168912778138891399955
Surprise %------------1.05%1.02%1.03%1.02%1.00%1.01%1.02%1.01%1.04%1.03%1.05%1.02%1.05%1.04%1.04%1.04%1.08%1.10%

Cigna's average Quarter revenue forecast for Mar 24 based on 4 analysts is $56.53B, with a low forecast of $56.50B, and a high forecast of $56.56B. CI's average Quarter revenue forecast represents a 10.60% increase compared to the company's last Quarter revenue of $51.11B (Dec 23).

Cigna EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts999988810126749168912778138891399955
EBITDA------------$1.03B$2.24B$2.22B$2.02B$2.36B$4.50B$3.03B$2.55B$2.33B$3.08B$2.92B$2.53B$6.42B$2.83B$3.35B$2.47B$2.57B$3.08B
Avg Forecast$4.93B$4.94B$4.60B$4.42B$4.62B$4.63B$4.39B$4.24B$4.48B$4.22B$4.13B$2.98B$3.47B$3.42B$3.36B$2.71B$2.53B$-3.34B$-3.31B$2.14B$-3.27B$-3.20B$-3.08B$2.33B$-2.98B$-2.93B$-2.82B$2.28B$-2.65B$-2.61B
High Forecast$5.13B$5.14B$4.78B$4.60B$4.80B$4.82B$4.57B$4.39B$4.72B$4.22B$4.14B$3.58B$3.52B$3.52B$3.49B$3.25B$3.04B$-3.34B$-3.31B$2.57B$-3.27B$-3.20B$-3.08B$2.80B$-2.98B$-2.93B$-2.82B$2.74B$-2.65B$-2.61B
Low Forecast$4.69B$4.70B$4.37B$4.20B$4.39B$4.40B$4.18B$4.05B$4.19B$4.22B$4.13B$2.38B$3.41B$3.34B$3.19B$2.17B$2.03B$-3.34B$-3.31B$1.71B$-3.27B$-3.20B$-3.08B$1.86B$-2.98B$-2.93B$-2.82B$1.82B$-2.65B$-2.61B
Surprise %------------0.30%0.66%0.66%0.74%0.93%-1.35%-0.91%1.19%-0.71%-0.96%-0.95%1.09%-2.15%-0.97%-1.19%1.08%-0.97%-1.18%

4 analysts predict CI's average Quarter EBITDA for Mar 24 to be $2.98B, with a high of $3.58B and a low of $2.38B. This is 189.58% upper than Cigna's previous annual EBITDA (Dec 23) of $1.03B.

Cigna Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts999988810126749168912778138891399955
Net Income------------$1.03B$41.00M$50.00M$1.27B$1.17B$2.76B$1.56B$1.18B$1.13B$1.62B$1.47B$1.16B$4.13B$1.39B$1.75B$1.18B$977.00M$1.35B
Avg Forecast$2.65B$2.59B$2.37B$2.25B$2.44B$2.35B$2.12B$1.96B$2.20B$2.03B$1.81B$1.38B$1.84B$1.88B$1.70B$1.26B$1.21B$1.62B$1.56B$993.45M$1.34B$1.48B$1.41B$1.07B$1.04B$1.21B$1.46B$1.09B$1.19B$1.24B
High Forecast$2.79B$2.73B$2.49B$2.37B$2.56B$2.47B$2.23B$2.18B$2.28B$2.05B$1.81B$1.66B$1.87B$1.93B$1.79B$1.51B$1.45B$1.62B$1.56B$1.19B$1.34B$1.48B$1.41B$1.28B$1.04B$1.21B$1.46B$1.31B$1.19B$1.24B
Low Forecast$2.48B$2.43B$2.22B$2.11B$2.28B$2.20B$1.98B$1.72B$2.17B$2.01B$1.81B$1.11B$1.82B$1.85B$1.59B$1.01B$969.57M$1.62B$1.56B$794.76M$1.34B$1.48B$1.41B$854.58M$1.04B$1.21B$1.46B$870.95M$1.19B$1.24B
Surprise %------------0.56%0.02%0.03%1.01%0.96%1.70%1.00%1.19%0.84%1.09%1.04%1.09%3.96%1.15%1.20%1.08%0.82%1.09%

Cigna's average Quarter net income forecast for Mar 24 is $1.38B, with a range of $1.11B to $1.66B. CI's average Quarter net income forecast represents a 34.34% increase compared to the company's last Quarter net income of $1.03B (Dec 23).

Cigna SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts999988810126749168912778138891399955
SG&A------------$4.06B$3.79B$3.43B$3.54B$3.48B$3.15B$3.26B$3.30B$3.66B$3.09B$3.00B$3.28B$3.97B$3.30B$3.41B$3.40B$3.96B$3.41B
Avg Forecast$5.60B$5.61B$5.22B$5.02B$5.24B$5.26B$4.99B$4.81B$5.09B$4.79B$4.69B$3.86B$3.94B$3.88B$3.81B$3.50B$3.98B$3.61B$3.58B$2.77B$3.54B$3.46B$3.32B$3.02B$3.22B$3.17B$3.05B$3.13B$2.87B$2.82B
High Forecast$5.82B$5.83B$5.43B$5.22B$5.45B$5.47B$5.19B$4.98B$5.36B$4.79B$4.69B$4.63B$3.99B$4.00B$3.96B$4.21B$4.77B$3.61B$3.58B$3.32B$3.54B$3.46B$3.32B$3.62B$3.22B$3.17B$3.05B$3.76B$2.87B$2.82B
Low Forecast$5.32B$5.33B$4.97B$4.77B$4.98B$5.00B$4.74B$4.60B$4.76B$4.79B$4.69B$3.08B$3.87B$3.79B$3.62B$2.80B$3.18B$3.61B$3.58B$2.22B$3.54B$3.46B$3.32B$2.41B$3.22B$3.17B$3.05B$2.51B$2.87B$2.82B
Surprise %------------1.03%0.98%0.90%1.01%0.88%0.87%0.91%1.19%1.04%0.89%0.90%1.09%1.23%1.04%1.12%1.08%1.38%1.21%

Cigna's average Quarter SG&A projection for Mar 24 is $3.86B, based on 4 Wall Street analysts, with a range of $3.08B to $4.63B. The forecast indicates a -5.10% fall compared to CI last annual SG&A of $4.06B (Dec 23).

Cigna EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts999988810126749168912778138891399955
EPS------------$3.49$4.79$4.96$4.28$3.83$9.07$4.95$3.71$3.38$4.84$4.30$3.33$11.96$3.81$4.77$3.19$2.64$3.60
Avg Forecast$9.41$9.22$8.42$8.00$8.66$8.36$7.53$6.96$7.83$7.23$6.43$6.22$6.54$6.68$6.03$5.26$4.86$5.72$5.49$5.18$4.72$5.22$4.96$4.37$3.68$4.24$5.15$4.36$4.20$4.36
High Forecast$9.90$9.70$8.85$8.41$9.11$8.79$7.92$7.75$8.09$7.30$6.43$6.22$6.63$6.85$6.34$5.53$5.12$5.72$5.49$5.18$4.72$5.22$4.96$4.37$3.68$4.24$5.15$4.36$4.20$4.36
Low Forecast$8.81$8.63$7.88$7.49$8.11$7.83$7.05$6.12$7.72$7.15$6.43$6.22$6.47$6.59$5.65$4.92$4.55$5.72$5.49$5.18$4.72$5.22$4.96$4.37$3.68$4.24$5.15$4.36$4.20$4.36
Surprise %------------0.53%0.72%0.82%0.81%0.79%1.59%0.90%0.72%0.72%0.93%0.87%0.76%3.25%0.90%0.93%0.73%0.63%0.83%

According to 4 Wall Street analysts, Cigna's projected average Quarter EPS for Mar 24 is $6.22, with a low estimate of $6.22 and a high estimate of $6.22. This represents a 78.22% increase compared to CI previous annual EPS of $3.49 (Dec 23).

Cigna Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CVSCVS Health$44.04$73.5066.89%Buy
CICigna$265.59$400.0050.61%Buy
ELVElevance Health$366.30$542.1448.00%Buy
CNCCentene$57.81$81.5040.98%Buy
UNHUnitedHealth Group$485.52$618.7527.44%Buy
HUMHumana$233.89$292.1324.90%Hold
MOHMolina Healthcare$291.78$347.0018.93%Hold
ALHCAlignment Healthcare$10.83$10.00-7.66%Buy

CI Forecast FAQ

Is Cigna a good buy?

Yes, according to 27 Wall Street analysts, Cigna (CI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 24 'Buy' recommendations, accounting for 88.89% of CI's total ratings.

What is CI's price target?

Cigna (CI) average price target is $400 with a range of $400 to $400, implying a 44.45% from its last price of $276.92. The data is based on 27 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cigna stock go up soon?

According to Wall Street analysts' prediction for CI stock, the company can go up by 44.45% (from the last price of $276.92 to the average price target of $400), up by 44.45% based on the highest stock price target, and up by 44.45% based on the lowest stock price target.

Can Cigna stock reach $400?

CI's average twelve months analyst stock price target of $400 does not support the claim that Cigna can reach $400 in the near future.

What are Cigna's analysts' financial forecasts?

Cigna's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $251.97B (high $261.75B, low $239.9B), average EBITDA is $17.88B (high $18.57B, low $17.02B), average net income is $8.86B (high $9.45B, low $8.19B), average SG&A $20.3B (high $21.08B, low $19.32B), and average EPS is $31.5 (high $33.58, low $29.1). CI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $266.22B (high $276.89B, low $253.16B), average EBITDA is $18.89B (high $19.65B, low $17.96B), average net income is $9.86B (high $10.37B, low $9.23B), average SG&A $21.44B (high $22.3B, low $20.39B), and average EPS is $35.04 (high $36.87, low $32.81).

Did the CI's actual financial results beat the analysts' financial forecasts?

Based on Cigna's last annual report (Dec 2023), the company's revenue was $195.26B, beating the average analysts forecast of $189.93B by 2.81%. Apple's EBITDA was $5.16B, missing the average prediction of $12.95B by -60.12%. The company's net income was $5.16B, missing the average estimation of $6.67B by -22.61%. Apple's SG&A was $14.82B, missing the average forecast of $15.13B by -2.04%. Lastly, the company's EPS was $17.39, missing the average prediction of $24.51 by -29.04%. In terms of the last quarterly report (Dec 2023), Cigna's revenue was $51.11B, beating the average analysts' forecast of $48.91B by 4.51%. The company's EBITDA was $1.03B, missing the average prediction of $3.47B by -70.35%. Cigna's net income was $1.03B, missing the average estimation of $1.84B by -44.06%. The company's SG&A was $4.06B, beating the average forecast of $3.94B by 3.11%. Lastly, the company's EPS was $3.49, missing the average prediction of $6.54 by -46.62%